CTOs on the Move

Portola

www.portola.com

 
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.portola.com
  • 270 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.246.7000

Executives

Name Title Contact Details

Similar Companies

Helix Medical

Helix Medical is a Carpinteria, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Office Service

Medical Office Service is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sensely

Sensely`s avatar and chatbot-based platforms assist insurance plan members and patients with the insurance services and healthcare resources they need, when they need it.

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.

Vytra Health Plans

Vytra Health Plans is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.